Friday 6 November 2026 Export BLCO’s income statement to Excel — free account

Bausch + Lomb Corporation

BLCO Healthcare Medical Instruments & Supplies

Bausch + Lomb Corporation’s revenue for fiscal 2025 (year ended December 2025) was $5.1 billion, up 6.47% from fiscal 2024.

Revenue: +7.34%
EPS: +222.4%
Free cash flow: +182.5%
Total debt: +2.93%

Quarter to September 2026, against a year earlier

19.94 0.66 −3.20%

Follow BLCO

Alert me

Market cap: $7.1B
P/E: 0.0×
Fwd P/E: 749×
Dividend yield: —
F-score: 3/9
Altman Z: 0.87
Beneish M: −2.52
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Bausch + Lomb Corporation (BLCO) Price to free cash flow

Alert me on Price to free cash flow

As of 5 November 2026, Bausch + Lomb Corporation (BLCO) trades at a price to free cash flow of 31.4×. Over the past ten years it has ranged from 0.0× (June 2026) to 72.8× (June 2023); the current reading is higher than 77% of that period. That is above the Medical Instruments & Supplies industry median of 23.5× and above the Healthcare sector median of 21.1×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/BLCO/price-to-free-cash-flow" width="100%" height="360" style="border:0" loading="lazy" title="Bausch + Lomb Corporation price to free cash flow, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/BLCO/metrics/price-to-free-cash-flow">Bausch + Lomb Corporation (BLCO) price to free cash flow — stockrow.com</a></p>

Period	Price to free cash flow	Change
FY2025	0.0×	—
FY2024	0.0×	—
FY2023	0.0×	—
FY2022	36.9×	162.70%
FY2021	14.1×	0.00%
FY2020	14.1×	—

Period	Price to free cash flow	Change
Sep 2026	26.8×	(49.28%)
Jun 2026	52.8×	—
Mar 2026	0.0×	—
Dec 2025	0.0×	—
19 more quarters	Free account

Against its own ten years

Low 0.0× High 72.8×

Ten-year median 0.0×

Current reading's percentile 77

Company	Price to free cash flow
MMED MiniMed Group, Inc. compare	n/m
ALGN Align Technology, Inc. compare	16.8×
COO The Cooper Companies, Inc. compare	18.1×
AVTR Avantor, Inc. compare	23.3×
MMSI Merit Medical Systems, Inc. compare	23.6×
ATR AptarGroup, Inc. compare	31.0×
BLCO Bausch + Lomb Corporation	31.4×
TFX Teleflex Incorporated compare	125×
RGEN Repligen Corporation compare	170×
Medical Instruments & Supplies industry median	23.5×
Healthcare sector median	21.1×
Market median	14.1×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

Bausch + Lomb Corporation (BLCO) Price to free cash flow

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on BLCO

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on BLCO

Stockrow Weekly